Total Payments
$396,178
2024 Payments
$59,630
Companies
37
Transactions
767
Medicare Patients
11,850
Medicare Billing
$1.2M
Payment Breakdown by Category
Other$288,001 (72.7%)
Consulting$54,873 (13.9%)
Travel$30,976 (7.8%)
Food & Beverage$21,891 (5.5%)
Education$189.40 (0.0%)
Gifts$166.39 (0.0%)
Research$81.35 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $192,866 | 82 | 48.7% |
| Compensation for serving as faculty or as a speaker for a medical education program | $65,525 | 14 | 16.5% |
| Consulting Fee | $54,873 | 34 | 13.9% |
| Travel and Lodging | $30,976 | 162 | 7.8% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $29,000 | 11 | 7.3% |
| Food and Beverage | $21,891 | 446 | 5.5% |
| Honoraria | $610.00 | 1 | 0.2% |
| Education | $189.40 | 4 | 0.0% |
| Gift | $166.39 | 3 | 0.0% |
| Unspecified | $81.35 | 10 | 0.0% |
Payments by Type
General
$396,097
757 transactions
Research
$81.35
1 transactions
Ownership
$0
9 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $104,434 | 196 | $0 (2022) |
| Aerie Pharmaceuticals, Inc. | $86,064 | 111 | $0 (2021) |
| Bausch & Lomb Americas Inc. | $76,090 | 112 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $43,486 | 69 | $0 (2021) |
| Alcon Vision LLC | $21,537 | 49 | $0 (2024) |
| ABBVIE INC. | $21,516 | 44 | $0 (2024) |
| Thea Pharma Inc. | $9,569 | 6 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $7,409 | 32 | $0 (2023) |
| W. L. Gore & Associates, Inc. | $5,722 | 11 | $0 (2024) |
| Shire North American Group Inc | $5,135 | 9 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $59,630 | 96 | Bausch & Lomb Americas Inc. ($54,851) |
| 2023 | $40,510 | 82 | Thea Pharma Inc. ($9,569) |
| 2022 | $43,225 | 77 | Bausch & Lomb Americas Inc. ($14,000) |
| 2021 | $41,504 | 80 | Allergan, Inc. ($29,754) |
| 2020 | $50,556 | 79 | Allergan, Inc. ($32,047) |
| 2019 | $109,568 | 220 | Aerie Pharmaceuticals, Inc. ($47,579) |
| 2018 | $37,052 | 81 | Aerie Pharmaceuticals, Inc. ($21,970) |
| 2017 | $14,134 | 52 | Novartis Pharmaceuticals Corporation ($4,943) |
All Payment Transactions
767 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $6,800.00 | General |
| Category: Ophthalmology | ||||||
| 12/10/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $6,800.00 | General |
| Category: Ophthalmology | ||||||
| 12/07/2024 | Sight Sciences, Inc. | OMNI SURGICAL SYSTEM (Device) | Food and Beverage | In-kind items and services | $62.94 | General |
| Category: Ophthalmology | ||||||
| 12/03/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Travel and Lodging | Cash or cash equivalent | $304.98 | General |
| Category: Ophthalmology | ||||||
| 12/03/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Travel and Lodging | Cash or cash equivalent | $238.26 | General |
| Category: Ophthalmology | ||||||
| 12/03/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Ophthalmology | ||||||
| 12/03/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Travel and Lodging | Cash or cash equivalent | $79.00 | General |
| Category: Ophthalmology | ||||||
| 12/03/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Travel and Lodging | Cash or cash equivalent | $65.19 | General |
| Category: Ophthalmology | ||||||
| 12/03/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Travel and Lodging | Cash or cash equivalent | $47.99 | General |
| Category: Ophthalmology | ||||||
| 12/03/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Travel and Lodging | Cash or cash equivalent | $40.45 | General |
| Category: Ophthalmology | ||||||
| 12/03/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Travel and Lodging | Cash or cash equivalent | $39.05 | General |
| Category: Ophthalmology | ||||||
| 12/03/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Travel and Lodging | Cash or cash equivalent | $33.50 | General |
| Category: Ophthalmology | ||||||
| 12/03/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $9.79 | General |
| Category: Ophthalmology | ||||||
| 12/03/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $8.99 | General |
| Category: Ophthalmology | ||||||
| 12/03/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $7.42 | General |
| Category: Ophthalmology | ||||||
| 12/03/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $6.78 | General |
| Category: Ophthalmology | ||||||
| 11/22/2024 | W. L. Gore & Associates, Inc. | Product in Development (Device) | Consulting Fee | Cash or cash equivalent | $520.00 | General |
| Category: Devices | ||||||
| 11/19/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Travel and Lodging | Cash or cash equivalent | $471.96 | General |
| Category: Ophthalmology | ||||||
| 11/19/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Travel and Lodging | Cash or cash equivalent | $192.66 | General |
| Category: Ophthalmology | ||||||
| 11/19/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $124.91 | General |
| Category: Ophthalmology | ||||||
| 11/19/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Travel and Lodging | Cash or cash equivalent | $58.82 | General |
| Category: Ophthalmology | ||||||
| 11/19/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Travel and Lodging | Cash or cash equivalent | $34.77 | General |
| Category: Ophthalmology | ||||||
| 11/19/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Travel and Lodging | Cash or cash equivalent | $26.09 | General |
| Category: Ophthalmology | ||||||
| 11/19/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Travel and Lodging | Cash or cash equivalent | $23.94 | General |
| Category: Ophthalmology | ||||||
| 11/19/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Travel and Lodging | Cash or cash equivalent | $15.00 | General |
| Category: Ophthalmology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent (XEN45) Implantation In Participants Aged 45 Years or Older With Open-Angle Glaucoma | AbbVie Inc. | $81.35 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 2,714 | 2,964 | $896,495 | $249,862 |
| 2022 | 25 | 3,034 | 3,275 | $949,435 | $267,657 |
| 2021 | 28 | 3,293 | 3,672 | $1.2M | $338,531 |
| 2020 | 25 | 2,809 | 3,069 | $1.1M | $296,084 |
Total Patients
11,850
Total Services
12,980
Medicare Billing
$1.2M
Procedure Codes
100
All Medicare Procedures & Services
100 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 323 | 371 | $102,025 | $34,483 | 33.8% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 500 | 538 | $72,630 | $26,159 | 36.0% |
| 65855 | Laser repair to improve eye fluid flow | Office | 2023 | 82 | 116 | $91,640 | $22,668 | 24.7% |
| 66180 | Creation of shunt to improve eye fluid flow using tissue graft | Facility | 2023 | 22 | 24 | $87,120 | $21,977 | 25.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 266 | 336 | $65,520 | $21,657 | 33.1% |
| 66172 | Creation of eye fluid drainage tract for treatment of glaucoma with previous scarring | Facility | 2023 | 15 | 16 | $60,960 | $15,569 | 25.5% |
| 65820 | Incision to improve eye fluid flow | Facility | 2023 | 20 | 21 | $56,175 | $14,305 | 25.5% |
| 66170 | Creation of eye fluid drainage tract for treatment of glaucoma | Facility | 2023 | 14 | 15 | $52,275 | $13,594 | 26.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 116 | 116 | $41,760 | $13,113 | 31.4% |
| 66183 | Insertion of eye fluid drainage device | Facility | 2023 | 12 | 13 | $42,640 | $11,063 | 25.9% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 30 | 38 | $41,040 | $10,295 | 25.1% |
| 92250 | Photography of the retina | Office | 2023 | 363 | 373 | $29,840 | $10,175 | 34.1% |
| 66761 | Creation of eye fluid drainage tracts in iris using a laser, per session | Office | 2023 | 20 | 32 | $31,040 | $7,688 | 24.8% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 18 | 22 | $38,060 | $6,384 | 16.8% |
| 92133 | Imaging of optic nerve | Office | 2023 | 186 | 188 | $15,040 | $5,197 | 34.6% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 236 | 240 | $14,400 | $4,897 | 34.0% |
| 66250 | Revision or repair of operative wound of eye | Facility | 2023 | 12 | 12 | $29,520 | $4,676 | 15.8% |
| 92145 | Measurement of corneal pressure | Office | 2023 | 170 | 171 | $5,130 | $1,610 | 31.4% |
| 68841 | Insertion of drug delivery implant into tear duct of eye | Facility | 2023 | 74 | 83 | $10,375 | $1,230 | 11.9% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 26 | 30 | $3,300 | $1,083 | 32.8% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 131 | 131 | $3,275 | $1,047 | 32.0% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 78 | 78 | $2,730 | $994.16 | 36.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 363 | 438 | $119,770 | $40,775 | 34.0% |
| 66180 | Creation of shunt to improve eye fluid flow using tissue graft | Facility | 2022 | 29 | 29 | $105,270 | $25,701 | 24.4% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 485 | 518 | $69,995 | $25,204 | 36.0% |
About Dr. Marlene Moster, M.D
Dr. Marlene Moster, M.D is a Ophthalmology healthcare provider based in Sunrise, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962475806.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marlene Moster, M.D has received a total of $396,178 in payments from pharmaceutical and medical device companies, with $59,630 received in 2024. These payments were reported across 767 transactions from 37 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($192,866).
As a Medicare-enrolled provider, Moster has provided services to 11,850 Medicare beneficiaries, totaling 12,980 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 100 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmology, Glaucoma Specialist
- Location Sunrise, FL
- Active Since 02/10/2006
- Last Updated 11/22/2023
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1962475806
Products in Payments
- VYZULTA (Drug) $121,574
- Rhopressa (Drug) $63,819
- DURYSTA (Drug) $61,642
- LUMIGAN (Drug) $50,839
- rocklatan (Drug) $15,384
- rhopressa (Drug) $14,724
- Rocklatan (Drug) $10,485
- Product in Development (Device) $5,722
- XIIDRA (Drug) $5,240
- SIMBRINZA (Biological) $4,759
- ALPHAGAN P (Drug) $4,686
- Simbrinza (Drug) $2,576
- TRAVATAN Z (Drug) $2,172
- Ahmed Glaucoma Valve (Device) $1,699
- XEN GLAUCOMA TREATMENT SYSTEM (Device) $1,237
- OMNI (Device) $838.45
- XEN (Device) $794.47
- Mitosol (Drug) $760.98
- CyPass (Device) $549.93
- iStent inject Trabecular Micro-Bypass Stent System (Device) $483.12
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Sunrise
Dr. Sergio Morello, M.d, M.D
Ophthalmology — Payments: $10,754
Ophthalmology $10,754
Henry Spratt, Md, MD
Ophthalmology — Payments: $8,115
Ophthalmology $8,115
Dr. Andrew Shatz, M.d, M.D
Ophthalmology — Payments: $4,384
Ophthalmology $4,384
Dr. Marc Goldberg, M.d, M.D
Ophthalmology — Payments: $2,933
Ophthalmology $2,933
Dr. Samuel Yankelove, M.d, M.D
Ophthalmology — Payments: $1,657
Ophthalmology $1,657
Seth Cutler, Md, MD
Ophthalmology — Payments: $884.90
Ophthalmology $884.90